Best Treatment for Upper Extremity Cellulitis
For uncomplicated upper extremity cellulitis without systemic signs, treat with oral antibiotics active against streptococci (such as cephalexin) for 5 days, with elevation of the affected limb and management of predisposing factors like edema or skin breakdown. 1
Antibiotic Selection Algorithm
Mild Cellulitis (No Systemic Signs)
- First-line: Oral anti-streptococcal agent (e.g., cephalexin, dicloxacillin) 1
- Oral antibiotics are as effective as IV therapy for uncomplicated cases 2
- Duration: 5 days, extend only if not improving 1
Moderate Cellulitis (Systemic Signs Present)
- Consider adding MRSA coverage if local prevalence is high 1
- In MRSA-prevalent areas, trimethoprim-sulfamethoxazole showed 91% success vs. 74% for cephalexin 3
- Clindamycin is another effective MRSA-active option 3
Severe Cellulitis (High-Risk Features)
Mandatory MRSA + streptococcal coverage if ANY of these present: 1
- Penetrating trauma
- Evidence of MRSA elsewhere
- Injection drug use
- Purulent drainage
- SIRS criteria met
Use vancomycin or similar agent active against both MRSA and streptococci 1
Critical Non-Antibiotic Interventions
These are NOT optional adjuncts—they are essential components of treatment: 1
- Limb elevation - Reduces edema and improves antibiotic penetration
- Address predisposing factors:
- Treat any skin breakdown or fissures
- Manage underlying edema/lymphedema
- Control obesity if present
- Treat tinea pedis/interdigital maceration (even for upper extremity, as this reduces recurrence risk) 1
Adjunctive Anti-Inflammatory Therapy
Consider adding oral NSAIDs (ibuprofen 400mg TID for 5 days) for faster early clinical response 4, 5. This may accelerate improvement at day 3, though the benefit doesn't persist beyond 4-5 days 4. The evidence shows no significant harm and potential early benefit 5.
When to Hospitalize
Admit if ANY of the following: 1
- SIRS criteria present
- Altered mental status
- Hemodynamic instability
- Concern for deeper/necrotizing infection
- Severely immunocompromised
- Poor adherence anticipated
Common Pitfalls to Avoid
Don't routinely culture uncomplicated cellulitis—blood and tissue cultures are only indicated with systemic signs, immunocompromise, or unusual exposures 1
Don't default to IV antibiotics—oral therapy is equally effective for uncomplicated cases and avoids unnecessary hospitalization 2
Don't ignore MRSA risk factors—in areas with high community-acquired MRSA prevalence, empiric coverage significantly improves outcomes (treatment failure 4.22 times higher without MRSA coverage) 3
Don't treat beyond 5 days unless clearly not improving—longer courses don't improve outcomes 1
Don't forget elevation and edema management—antibiotics alone are insufficient if mechanical factors perpetuate infection 1
Strength of Evidence
The IDSA 2014 guidelines 1 provide the most authoritative framework, with strong-to-moderate quality evidence for most recommendations. The oral vs. IV equivalence is supported by randomized trial data 2, and MRSA coverage recommendations are validated by retrospective cohort data from high-prevalence settings 3. The anti-inflammatory adjunct data is emerging but based on small trials 4, 5.